hemangioma/driska

Povezava se shrani v odložišče

Članki Kliničnih preskušanjPatenti

Izberite vrsto razvrščanja

Stran 1 iz 27 rezultatov

Diarrhea associated with propranolol treatment for hemangioma of infancy (HOI).

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Rapidly growing giant solitary cavernous hemangioma in a patient with ulcerative colitis.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Cavernous hemangiomas are rare lesions of the colon that usually present with painless, recurrent bleeding. Hemangiomas can be capillary or cavernous type, and 80% of rectal hemangiomas are cavernous type. Ulcerative colitis is an inflammatory disorder that affects the rectum and, occasionally, the

Effects of systemic propranolol treatment on physical growth of patients with infantile hemangiomas.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Propranolol has been widely used in the treatment of infantile hemangiomas since 2008. This study aimed to investigate complications of systemic propranolol therapy for infantile hemangiomas, especially its effect on infants' physical growth. In this study, propranolol was given at a dose of 2 mg/kg

Evolving treatments in the management of laryngotracheal hemangiomas: will propranolol supplant steroids and surgery?

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

There has been a dramatic evolution in the treatment of laryngotracheal hemangiomas during the past decade and recent accounts and case reports of propranolol treatment have been encouraging. The purpose of the study is to determine the clinical course and outcomes of treating laryngotracheal

Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

BACKGROUND Despite not being licensed for the treatment of infantile hemangiomas (IH) in infants younger than 5 weeks or older than 5 months, propranolol is often used in these age groups to prevent or to treat potentially severe complications. The objective of the present study was to review the

Propranolol intervention therapy for infants with facial hemangioma.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

OBJECTIVE The current study aimed to evaluate the clinical efficacy and adverse effects of small doses of propranolol intervention therapy for infants with infantile facial hemangioma in the proliferation stage. METHODS A total of 22 patients including 9 males and 13 females with an average age of

[Treatment of infantile hemangiomas with low-dose propranolol: evaluation of short-term efficacy and safety].

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

OBJECTIVE To evaluate the short-term efficacy and safety of propranolol in the treatment of infantile hemangiomas. METHODS Between October 2008 and May 2009, oral propranolol was applied to 58 infants with hemangiomas at a dose of 1.0 - 1.5 mg per kilogram of body weight per day in Linyi, Shandong

Therapeutic efficacy of propranolol for infantile hemangiomas.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

This was a retrospective study to analyze the clinical therapeutic efficacy of propranolol in patients with infantile hemangioma (IH).Patients with IH were treated with propranolol (2-4.5 mg/kg/day). Those patients who did not have a good response to

Propranolol for problematic head and neck hemangiomas: an analysis of 37 consecutive patients.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

OBJECTIVE Infantile hemangiomas (IHs) on head and neck are frequently encountered. Recently, propranolol was introduced as a novel pharmacologic treatment for IH. But the impact of propranolol for the treatment of IHs especially the side effects have not yet been well described. This article aimed

[Propranolol in the treatment of infantile hemangioma: clinical effectiveness, risks, and recommendations].

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

The therapeutic arsenal for hemangiomas in early childhood can now be considered to include oral β-blockers, mainly propranolol. These drugs are thought to act as vasoconstrictors, regulating angiogenic pathways and inducing apoptosis of vascular endothelial cells. Although infantile hemangioma is

Clinical Outcomes of Infants With Periorbital Hemangiomas Treated With Oral Propranolol.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

OBJECTIVE Periorbital infantile hemangiomas (IHs) require early intervention because they have the potential risk of causing visual disturbances. In recent years, propranolol has shown promise in the effective management of periocular and periorbital IHs. The objective of our study was to assess the

Treatment with propranolol for infantile hemangiomas: A case series of 106 infants.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

The aim of the present study was to investigate the clinical benefit and side effects of propranolol treatment in 106 children with infantile hemangiomas (IHs). A retrospective chart review was conducted on all children who attended the clinic between September 16, 2009 and November 11, 2013.

Immunodeficiency secondary to structural intestinal defects. Malrotation of the small bowel and cavernous hemangioma of the jejunum.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Two patients with gastrointestinal tract abnormalities were discovered to have significant defects in both humoral and cellular immunity. Patient 1, a 4-year-old girl with suspected food allergy, failure to thrive, and chronic diarrhea, exhibited a decreased serum IgG immunoglobulin level, decreased

Preliminary experience on treatment of infantile hemangioma with low-dose propranolol in China.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

We aimed to assess the efficacy and safety of low-dose propranolol for treatment of infantile hemangiomas (IHs) in China. Our prospective study included data from 89 patients with IH, aged 1-12 months. Plasma renin activity, angiotensin II, and aldosterone were measured before initiation of

Coexistence of splenic hemangioma and vascular malformation of the vertebrae.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

BACKGROUND Cavernous hemangioma is an encapsulated mass of dilated, endothelial lined vascular channels filled with slowly flowing blood. Cavernous hemangioma of the spleen is a rare condition with less than 100 reports so far. Hemangioma of the vertebral is a benign vascular legion around one or

Prejšnji
1
2
Naslednji

Pridružite se naši
facebook strani

Herbal & Natural Medicine

Najbolj popolna baza zdravilnih zelišč, podprta z znanostjo

Deluje v 55 jezikih
Zeliščna zdravila, podprta z znanostjo
Prepoznavanje zelišč po sliki
Interaktivni GPS zemljevid - označite zelišča na lokaciji (kmalu)
Preberite znanstvene publikacije, povezane z vašim iskanjem
Iščite zdravilna zelišča po njihovih učinkih
Organizirajte svoje interese in bodite na tekočem z raziskavami novic, kliničnimi preskušanji in patenti

Vnesite simptom ali bolezen in preberite o zeliščih, ki bi lahko pomagala, vnesite zelišče in si oglejte bolezni in simptome, proti katerim se uporablja.
* Vse informacije temeljijo na objavljenih znanstvenih raziskavah